Assessing Cardiovascular Benefits of Intensive Blood Pressure Lowering in High-Risk Undiagnosed HFpEF Patients
The HFpEF-ABA score identifies high-risk patients with undiagnosed HFpEF who have elevated cardiovascular event rates and benefit from intensive blood pressure control without an increased risk of serious adverse events.
Authors
- J Zhang
- Chenxi Jiang (ORCID: https://orcid.org/0000-0001-9131-0589)
- Xin Du (ORCID: https://orcid.org/0000-0002-9004-8758)
- Chang Hua (ORCID: https://orcid.org/0009-0001-9324-6987)
- Jianzeng Dong (ORCID: https://orcid.org/0000-0002-2105-3852)
- Yanfang Wu
- Jingwei Liu (ORCID: https://orcid.org/0000-0002-5444-9060)
- Yan Xiong (ORCID: https://orcid.org/0000-0001-6343-7806)
- Zhiyan Wang (ORCID: https://orcid.org/0000-0001-7791-0748)
- Xinru Liu (ORCID: https://orcid.org/0009-0008-7483-7993)
- Yangyang Tang (ORCID: https://orcid.org/0009-0007-5360-6304)
- Qiang Lv
Institutions
- American Heart Association (US)
- Beijing Anzhen Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1002/ehf2.15435
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00